Skip to content

Tisuacryl® in Dental Hyperesthesia

Tisuacryl® in Dental Hyperesthesia. Clinical Trial Phase III

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
RPCEC
Registry ID
RPCEC00000064
Enrollment
160
Registered
2008-09-18
Start date
2007-09-10
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Hyperesthesia

Interventions

Patients with dental hyperesthesia as evidenced by clinical history, underwent one minute, antiseptic mouth rinsing with clorhexidine 0,2%, the operative mouth field is set, the tooth surface is dried
Chlorhexidine

Sponsors

Center of Biomaterials of Havana University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients older than 20 years old and younger than 75 years old with dental hyperesthesia who consented to participate in the clinical trial

Exclusion criteria

Exclusion criteria: Patients with malignant neoplasia in areas close to the site of treatment. Patients with mental incapacity and/or severe psychological disorders Pregnant or breastfeeding women Patients with allergic reactions to gentian violet or acrylics Patients with uncontrolled diabetes Patients with alcoholism or other drugs addictions Patients that do not consent to participate in the study

Design outcomes

Primary

MeasureTime frame
Pain relief, 48 hours, 96 hours, 5 days, 6 days No adverse reactions, up to 6 days

Secondary

MeasureTime frame
Irritation of oral mucosa around the site after the application of the product, 48 hours, 96 hours, 5 days, 6 days. Warmth on treated area, 48 hours, 96 hours, 5 days, 6 days.

Countries

Cuba

Contacts

Public ContactRosa Guerra Bretaña

Center of Biomaterials of Havana University

mayelin@biomat.uh.cu

Outcome results

None listed

Source: RPCEC (via WHO ICTRP) · Data processed: Apr 4, 2026